In Silico Prediction and Design of Uropathogenic Escherichia coli Alpha-Hemolysin Generate a Soluble and Hemolytic Recombinant Toxin
Authors:
- Bruna De Lucca CaetanoBCBruna De Lucca Caetano
- Marta de Oliveira DomingosMDMarta de Oliveira Domingos
- Miriam Aparecida da SilvaMSMiriam Aparecida da Silva
- Jessika Cristina Alves da SilvaJSJessika Cristina Alves da Silva
- Juliana Moutinho PolattoJPJuliana Moutinho Polatto
- Fabio MontoniFMFabio Montoni
- Leo Kei IwaiLILeo Kei Iwai
- Daniel Carvalho PimentaDaniel Carvalho Pimenta
- Hugo VigerelliHVHugo Vigerelli
- Paulo Cesar Gomes VieiraPVPaulo Cesar Gomes Vieira
- Rita de Cassia RuizRRRita de Cassia Ruiz
- José Salvatore PatanéJPJosé Salvatore Patané
Open Access
- 14 January 2022
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 10 (1) , 172
Abstract
The secretion of α-hemolysin by uropathogenic Escherichia coli (UPEC) is commonly associated with the severity of urinary tract infections, which makes it a predictor of poor prognosis among patients. Accordingly, this toxin has become a target for diagnostic tests and therapeutic interventions. However, there are several obstacles associated with the process of α-hemolysin purification, therefore limiting its utilization in scientific investigations. In order to overcome the problems associated with α-hemolysin expression, after in silico prediction, a 20.48 kDa soluble α-hemolysin recombinant denoted rHlyA was constructed. This recombinant is composed by a 182 amino acid sequence localized in the aa542–723 region of the toxin molecule. The antigenic determinants of the rHlyA were estimated by bioinformatics analysis taking into consideration the tertiary form of the toxin, epitope analysis tools, and solubility inference. The results indicated that rHlyA has three antigenic domains localized in the aa555–565, aa600–610, and aa674–717 regions. Functional investigation of rHlyA demonstrated that it has hemolytic activity against sheep red cells, but no cytotoxic effect against epithelial bladder cells. In summary, the results obtained in this study indicate that rHlyA is a soluble recombinant protein that can be used as a tool in studies that aim to understand the mechanisms involved in the hemolytic and cytotoxic activities of α-hemolysin produced by UPEC. In addition, rHlyA can be applied to generate monoclonal and/or polyclonal antibodies that can be utilized in the development of diagnostic tests and therapeutic interventions.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/17178-2, 2018/13895-0)
This publication has 27 references indexed in Scilit:
- In Silico Toxicology – Non-Testing MethodsFrontiers in Pharmacology, 2011
- RTX proteins: a highly diverse family secreted by a common mechanismFEMS Microbiology Reviews, 2010
- Inactivation of Host Akt/Protein Kinase B Signaling by Bacterial Pore-forming ToxinsMolecular Biology of the Cell, 2008
- Role of the Lipopolysaccharide-CD14 Complex for the Activity of Hemolysin from Uropathogenic Escherichia coliInfection and Immunity, 2007
- Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of miceVaccine, 2007
- Release of the type I secreted α‐haemolysin via outer membrane vesicles from Escherichia coliMolecular Microbiology, 2005
- SWISS-MODEL: an automated protein homology-modeling serverNucleic Acids Research, 2003
- The different hemolysins of Escherichia coliMedical Microbiology and Immunology, 1991
- An in vitro alternative to the Draize eye-irritation test: Evaluation of the crystal violet staining methodToxicology in Vitro, 1991
- Prediction of protein antigenic determinants from amino acid sequences.Proceedings of the National Academy of Sciences, 1981